The breast cancer in women remains the most frequent with about 30 percent and the rate continues to increase. Happily, parallel to this increase, the diagnosis is done earlier so that the survival is better and treatment becomes less severe. We have several hypotheses for the cause but no one is certain. Risk factors, forecast factors and clinical staging have been established to permit comparable clinical studies and to evaluate treatment efficiency.